Monte Rosa, Novartis Use AI-Powered Engine To Advance Immune Disease Treatments

Monte Rosa Therapeutics Inc. (NASDAQ:GLUE) stock is surging on Monday, with a session volume of 11.67 million compared to the average volume of 408.08 thousand as per data from Benzinga Pro.

Monte Rosa announced a collaboration with Novartis AG (NYSE:NVS) to develop novel degraders for immune-mediated diseases.

Under the terms of the agreement, Monte Rosa will receive an upfront payment of $120 million. Monte Rosa will also receive payments to maintain the options.

In total deal value, Monte Rosa is eligible to receive up to $5.7 billion, including upfront, ...